Alzheimer's Disease
Explore our articles on Alzheimer's disease and cognitive health, including treatment options, clinical evidence, safety and costs. Each guide offers clear, practical information to help you understand your options and know when to seek personalized care.
Alzheimer's Disease Medications: Do the Benefits Outweigh the Risks?
A review of the clinical evidence, safety concerns, and costs of Kisunla and Leqembi, the FDA-approved medications that modify Alzheimer's disease progression.
Alzheimer's Disease: Concerned About Your Memory or Cognitive Decline?
Learn how genetic risk testing and blood-based biomarkers support a more comprehensive assessment of Alzheimer's disease and cognitive decline.
Alzheimer's Disease: Understanding Your Treatment Options
An overview of current Alzheimer's medications, from symptom management to treatments that slow progression, and the risks to weigh before choosing.
Fungal Infections and Alzheimer's Disease: What Does the Research Show?
A look at what research says about fungal organisms, mycotoxins, and Alzheimer's disease, and what the findings do and do not establish.
Viral Infections Linked to Alzheimer's, Parkinson's, ALS, and Other Neurodegenerative Diseases
An analysis of nearly 500,000 medical records identified associations between certain viral infections and an increased risk of neurodegenerative diseases.
LL-37 and Alzheimer's Disease: Research Overview
Researchers are studying how the immune peptide LL-37 interacts with amyloid-beta, with findings that point in two opposing directions.